NCCN临床实践指南_小细胞肺癌(2019.V2)英文版
64页1、NCCN org Version 2 2019 08 05 19 2019 National Comprehensive Cancer Network NCCN All rights reserved NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN NCCN Clinical Practice Guidelines in Oncology NCCN Guidelines Small Cell Lung Cancer Version 2 2019 August 5 2019 Continue Gregory P Kalemkerian MD Chair University of Michigan Rogel Cancer Center Billy W Loo Jr MD PhD Vice Chair Stanford Cancer Institute Wallace Akerley MD Hunts
2、man Cancer Institute at the University of Utah Albert Attia MD Vanderbilt Ingram Cancer Center Michael Bassetti MD University of Wisconsin Carbone Cancer Center Collin Blakely MD PhD UCSF Hellen Diller Family Comprehensive Cancer Center Yanis Boumber MD PhD Fox Chase Cancer Center Alberto Chiappori MD Moffitt Cancer Center Thomas A D Amico MD Duke Cancer Institute Roy Decker MD PhD Yale Cancer Center Smilow Cancer Hospital M Chris Dobelbower MD PhD University of Alabama at Birmingham Comprehensi
3、ve Cancer Center Afshin Dowlati MD Case Comprehensive Cancer Center University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute Robert J Downey MD Memorial Sloan Kettering Cancer Center Anna Farago MD PhD Massachusetts General Hospital Cancer Center Charles Florsheim Patient Advocate Apar Kishor P Ganti MD Fred T1 4 N1 3 M0 Also for SCL 4 SCL 3 Testing Results option was split into two different pathways Medically inoperable or decision made not to pursue surgical re
4、section and Pathologic mediastinal staging positive Initial Treatment Medically inoperable or decision made not to pursue surgical resection SABR or Systemic therapy concurrent RT See SCL 4 was added Adjuvant Treatment Medically inoperable or decision made not to pursue surgical resection Systemic therapy was added SCL 6 Response Assessment Following Initial Therapy Bullet 2 was revised Brain MRI preferred or CT with contrast if prophylactic cranial irradiation PCI to be given Chest x ray option
5、al was removed Adjuvant Treatment Extensive stage bullet was split into two statements Consider PCI or MRI brain surveillance and Consider thoracic RT Surveillance Bullet 1 was added Provide Survivorship Care Plan after completion of initial therapy Bullet 3 was revised If PCI not given then MRI preferred or CT brain with contrast every 3 4 mo during y 1 2 was changed to MRI preferred or CT brain with contrast every 3 4 months during y 1 then every 6 months during y 2 regardless of PCI status Fo
《NCCN临床实践指南_小细胞肺癌(2019.V2)英文版》由会员沧海****3分享,可在线阅读,更多相关《NCCN临床实践指南_小细胞肺癌(2019.V2)英文版》请在金锄头文库上搜索。
洁厕灵企业技术标准范例
发电企业热工设备检修规程
发电企业热控日常点检标准
发电企业汽机(含燃机)技术监督细则
发电企业电气设备保护及安全自动装置投退和定值变更管理标准
继电保护定值变更通知单
继电保护及安全自动装置投退审批表
电气保护定值更改申请单
化工企业粉尘涉爆企业整体安全风险等级评估方法
化工企业安全检查管理规程
电气安全管理规程范例
农业企业绿色食品大棚生菜生产操作规程
农业企业绿色食品桃园管理规程
农业企业绿色食品早春蕹菜生产操作规程
农业企业绿色食品大棚蚕豆促早栽培生产技术操作规程
农业企业绿色食品荠菜种植规程
农业企业绿色食品青椒种植规程
农业企业绿色食品筒篙种植规程
农业企业绿色食品油麦菜种植规程
农业企业绿色食品木耳菜种植规程
2023-05-11 11页
2022-09-05 10页
2022-08-18 10页
2022-08-18 6页
2022-08-18 7页
2022-08-18 3页
2022-08-18 5页
2022-08-18 9页
2022-08-18 7页
2022-08-18 4页